HHcy also appears to exacerbate the effects of other factors implicated in Alzheimer's disease pathology, such as increasing N-homocysteinylated levels of tau and Aβ 4,21. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.